Our biopolymer-based Clo-Sur P.A.D. promotes hemostasis through its innovative formulation, structure and positive ionic charge. When Clo-Sur P.A.D. is applied to a wound, its positive charge immediately begins working to rapidly control bleeding. In-vitro laboratory studies have shown this occurs at a faster rate than many competing products1.
Through the use of Clo-Sur P.A.D., hospitals and clinical facilities have the ability to dramatically reduce time to ambulation and discharge, providing an opportunity for tremendous increases in both patient flow and cost efficiencies: